The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 30 of 47 cases over the following month. The odds of a continued upward trend are 64%.
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +1.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 210 of 331 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The 10-day RSI Indicator for CNO moved out of overbought territory on November 03, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 40 similar instances where the indicator moved out of overbought territory. In 22 of the 40 cases, the stock moved lower in the following days. This puts the odds of a move lower at 55%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 68 cases where CNO's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 49%.
The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CNO as a result. In 43 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CNO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 62 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.980) is normal, around the industry mean (1.337). P/E Ratio (18.733) is within average values for comparable stocks, (19.773). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.013) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
JXN moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend. In 42 of 46 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 45 of 56 cases where JXN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on JXN as a result. In 64 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for JXN just turned positive on October 22, 2026. Looking at past instances where JXN's MACD turned positive, the stock continued to rise in 37 of 44 cases over the following month. The odds of a continued upward trend are 84%.
The 10-day moving average for JXN crossed bullishly above the 50-day moving average on November 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 12 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 86%.
Following a +2.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where JXN advanced for three days, in 290 of 376 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
The Aroon Indicator entered an Uptrend today. In 197 of 269 cases where JXN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where JXN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
JXN broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is 1 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 8 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 61, placing this stock better than average.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. JXN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 92 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.946) is normal, around the industry mean (1.337). JXN's P/E Ratio (143.141) is considerably higher than the industry average of (19.773). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.463). Dividend Yield (0.027) settles around the average of (0.047) among similar stocks. P/S Ratio (1.511) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
CNO | ||
|---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 62 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 41 | |
P/E GROWTH RATING 1..100 | 14 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| CNO | JXN | |
|---|---|---|
| RSI ODDS (%) | 4 days ago 55% | N/A |
| Stochastic ODDS (%) | 4 days ago 49% | 4 days ago 80% |
| Momentum ODDS (%) | 4 days ago 49% | 4 days ago 74% |
| MACD ODDS (%) | 4 days ago 64% | 4 days ago 84% |
| TrendWeek ODDS (%) | 4 days ago 62% | 4 days ago 77% |
| TrendMonth ODDS (%) | 4 days ago 61% | 4 days ago 76% |
| Advances ODDS (%) | 6 days ago 63% | 6 days ago 77% |
| Declines ODDS (%) | 11 days ago 46% | 11 days ago 62% |
| BollingerBands ODDS (%) | 4 days ago 54% | 4 days ago 67% |
| Aroon ODDS (%) | 4 days ago 62% | 4 days ago 73% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green while JXN’s FA Score has 2 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 5 TA indicator(s) are bullish while JXN’s TA Score has 7 bullish TA indicator(s).
CNO (@Life/Health Insurance) experienced а +3.64% price change this week, while JXN (@Life/Health Insurance) price change was +5.51% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +0.49%. For the same industry, the average monthly price growth was +2.06%, and the average quarterly price growth was -2.59%.
CNO is expected to report earnings on Feb 09, 2027.
JXN is expected to report earnings on Feb 24, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
A.I.dvisor indicates that over the last year, JXN has been loosely correlated with LNC. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if JXN jumps, then LNC could also see price increases.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| SSPC | 8.66 | 0.13 | +1.52% |
| Leverage Shares 2X Short SPCX Daily ETF (SSPC) | |||
| SAMT | 40.54 | 0.05 | +0.14% |
| Strategas Macro Thematic Opportunities ETF (SAMT) | |||
| LJAN | 24.72 | 0.01 | +0.02% |
| Innovator Premium Income 15 Buffer ETF - January (LJAN) | |||
| SCHP | 25.18 | -0.05 | -0.20% |
| Schwab US TIPS ETF (SCHP) | |||
| BFEB | 53.74 | -0.13 | -0.24% |
| Innovator U.S. Equity Buffer ETF - February (BFEB) | |||